ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Tuesday, 17 September 2013

Latest Study On Mesenchymal Stem Cells - Advances & Applications 2013 Available At include new market research report"Mesenchymal Stem Cells - Advances & Applications 2013 " to its huge collection of research reports.

Understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research.
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Recently, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures, and more.

Trend analysis of grant activity, scientific publication rates, and patent applications trends reveal that global research activity involving mesenchymal stem cells (MSCs) increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Of most interest is that this rate of growth accelerated throughout 2011, making mesenchymal stem cells the fastest growing area of stem cell research.

Because mesenchymal stem cell researchers represent a rapidly growing, well-funded research community, this report presents strategies for research supply companies to use to develop high-demand products for this community. A key element of this report is a survey of mesenchymal stem cell (MSC) researchers. This survey reveals critical findings that include:
Preferred Tissue Source for MSCs
Preferred Species Source for MSCs
MSC Product Preferences
Most Commonly Utilized MSC Antibodies
Terms Used in Online Search (for targeting your ads with precision) 

It is also important for bio-pharmaceutical and pharma companies interested in mesenchymal stem cell therapy applications to understand underlying market forces, and in particular, to consider progressive areas of MSC research as opportunistic areas for drug and therapy development. This report presents a range of topics of interest to these companies as well, including how advances in MSC research can reveal potential new drug targets, improve methods of drug delivery, and provide personalized treatment strategies.
Highlights of this report include:

Charts, Timelines, Metrics and Financials
Rates of MSC Grants, Publications, and Patents
Market Characterization and 5-Year Projections
Breakdown of MSC Research Activity by Application, Species, Tissue Source
Geographical Assessment of Market Demand
Competitive Environment Analysis, by MSC Product Supplier
Recent Product Evolution and Unmet Market Needs
Online Advertising Assessment and Opportunities for Targeted Traffic
Revealing Survey of Your Prospective Clients MSC Scientists
End-User Wants, Technical Preferences, Factors Influencing Buying Decisions

And Much More... 
The market intelligence contained in this report was compiled using a broad range of sources, including:

MSC grant funding (NIH database, DoD database)
MSC patents (USPTO)
MSC publications (PubMed, Highwire Press)
MSC product launch announcements (Google News, Trade Journals)
International surveys (electronically distributed end-user surveys)

And more 
These sources were used to identify recent advances in MSC research applications, explore research priorities by market segment, highlight individual labs and end-users of MSC research products, explore the competitive environment for MSC research products, and provide 5-year growth and trend analysis. As such, this market intelligence report will advantageously position your company to offer competitive MSC products to this rapidly growing, well-funded research community.
You'll also access information on:

Recent Product Evolution
Projected Directions for Development
Overview of Therapeutic Progress and Insight into Future Applications
Detailed Evaluation of Profit Opportunities for Research Product Suppliers 

In summary, literature and data concerning the biology and differentiation potential of mesenchymal stem cells (MSCs) has become huge in less than 10 years, now totaling nearly 13,000 publications, although some data does present as contradictory, suggesting a heterogenic nature for MSC populations depending on source tissue, species, and donor characteristics. MSCs appear to be an exceptionally promising tool for cell therapy because of their unusual characteristics, which partially mimic those of embryonic stem cells, but have advantages in terms of availability, expandability, transplantability, and ethical implications.

Interest in therapeutic applications of human MSCs arises from their diverse ability to differentiate into a range of cell types, as well as from their ability to migrate to sites of tissue injury/inflammation or tumor growth. These localization properties present a promising strategy for targeted introduction of therapeutic agents through MSC gene therapy. In addition, MSCs possess strong immunosuppressive properties that medical researchers are exploiting for both autologous as well as heterologous therapies.

Characterized by these properties, it not surprising that trend analysis reveals rapid increases in research activity involving mesenchymal stem cells. With scientific publication rate increases of 112% year-over-year from 2009 to 2010, and 116% from 2010 to 2011, this report will help you understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research. 

Visit All Biotechnology Market Research Reports @

For More Information Kindly Contact:


Post a Comment